Purple Biotech Stock (NASDAQ: PPBT) stock price, news, charts, stock research, profile.
Open | $0.470 |
Close | $0.455 |
Volume / Avg. | 52.314K / 114.766K |
Day Range | 0.443 - 0.490 |
52 Wk Range | 0.302 - 2.098 |
Market Cap | $11.727M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 30 |
Short Interest | - |
Days to Cover | 2.3 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Purple Biotech (NASDAQ: PPBT) through any online brokerage.
Other companies in Purple Biotech’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), Kiora Pharmaceuticals (NASDAQ:KPRX) and Universe Pharmaceuticals (NASDAQ:UPC).
The latest price target for Purple Biotech (NASDAQ: PPBT) was reported by Chardan Capital on Thursday, March 7, 2024. The analyst firm set a price target for 11.00 expecting PPBT to rise to within 12 months (a possible 2337.94% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Purple Biotech (NASDAQ: PPBT) is $0.4512 last updated April 18, 2024 at 6:06 PM EDT.
There are no upcoming dividends for Purple Biotech.
Purple Biotech’s Q1 earnings are confirmed for Tuesday, May 14, 2024.
There is no upcoming split for Purple Biotech.
Purple Biotech is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.